Galapagos is a commercial-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos is seeking research focused on kidney diseases such as chronic kidney diseases including polycystic kidney disease (PCKD), diabetic kidney disease and Alport syndrome.
Targets and Therapeutic Interventions
Technology
Centre of Excellence
Spinout Company
Academic Researcher
Research Project
Technology
Centre of Excellence
Spinout Company
Academic Researcher
Research Project
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.